The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,050.00
Bid: 12,038.00
Ask: 12,040.00
Change: -106.00 (-0.87%)
Spread: 2.00 (0.017%)
Open: 12,092.00
High: 12,178.00
Low: 12,010.00
Prev. Close: 12,156.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Monday broker round-up UPDATE

Mon, 13th Oct 2014 09:32

Amino Technologies: Northland Capital upgrades to buy with a target price of 100p.Anglo American: Canaccord Genuity initiates with a target price of 1720p and a buy recommendation. Credit Suisse upgrades to outperform with a target price of 1800p.Associated British Foods: Societe Generale upgrades to buy with a target price of 2950p.AstraZeneca: Jefferies raises target price from 4500p to 5000p upgrading to buy.Betfair Group: Numis reduces target price from 1250p to 940p downgrading to reduce.Bodycote: Investec cuts target price from 775p to 750p and stays with its buy recommendation.Brammer: Investec cuts target price from 435p to 400p, while keeping a buy recommendation.Brown (N) Group: N+1 Singer reduces target price from 585p to 390p, while staying with its buy recommendation. Jefferies cuts target price from 540p to 406p and reiterates a buy recommendation.BTG: Investec raises target price from 728p to 832p staying with its buy recommendation.bwin.party: Numis cuts target price from 200p to 180p and keeps a buy recommendation.Coca-Cola HBC: Credit Suisse reduces target price from 1500p to 1400p, while maintaining its neutral rating.Dialight: Investec reduces target price from 910p to 850p downgrading to sell.Domino Printing: Investec cuts target price from 650p to 615p keeping an add rating.Eagle Eye: Panmure Gordon initiates with a target price of 229p and a buy recommendation.Fenner: Investec cuts target price from 320p to 270p and retains a sell recommendation.Ferrexpo: Cantor Fitzgerald reduces target price from 250p to 120p maintaining a buy recommendation.GKN: Investec cuts target price from 380p to 330p, while upgrading from add to buy.GlaxoSmithKline: Jefferies ups target price from 1385p to 1400p and retains a hold recommendation.Glencore: Canaccord Genuity initiates with a target price of 400p and a buy recommendation.Halma: Investec lowers target price from 635p to 630p and maintains a buy recommendation.Hellermann Tyton: Investec lowers target price from 305p to 300p and retains a hold recommendation.IMI: Investec reduces target price from 1560p to 1425p and keeps a buy recommendation.IMImobile: WH Ireland ups target price from 175p to 187p and retains a buy recommendation.Jupiter Fund Management: JP Morgan cuts target price from 465p to 400p staying with an overweight rating. Espirito Santo cuts target price from 489p to 469p leaving its buy recommendation unaltered.Ladbrokers: Numis reduces target price from 150p to 100p downgrading to reduce.Laird: Investec lowers target price from 260p to 250p leaving its sell recommendation unchanged.Melrose: Investec shifts target price from 332p to 335p and keeps a buy recommendation.Molins: Panmure Gordon reduces target price from 250p to 165p and stays with its buy recommendation.Morgan Advanced Materials: Investec lowers target price from 345p to 335p reiterating its buy recommendation.Oxford Instruments: Investec reduces target price from 1520p to 1405p and reiterates a buy recommendation.Paragon Group: JP Morgan ups target price from 396p to 420p and leaves its overweight rating unchanged.Playtech: Numis cuts target price from 700p to 665p and reiterates a hold recommendation.Renishaw: Investec reduces target price from 1900p to 1775p keeping a buy recommendation.Rotork: Investec reduces target price from 2840p to 2610p retaining its add rating.Smith (DS): Investec cuts target price from 380p to 350p and stays with its buy recommendation.Smith & Nephew: Investec reduces target price from 1100p to 1023p and downgrades from add to hold.Smith (WH): Canaccord Genuity initiates with a target price of 1225p and a buy recommendation.Spectris: Investec reduces target price from 2580p to 2380p and maintains a buy recommendation.Spirax-Sarco: Investec reduces target price from 2920p to 2810p and stays with its add rating.TSB: Investec shifts target price from 290p to 295p upgrading from hold to buy.Vedanta Resources: Canaccord Genuity initiates with a target price of 1020p and a hold recommendation. JP Morgan lowers target price from 1140p to 1130p and retains its neutral rating.Vesuvius: Investec cuts target price from 485p to 450p and reiterates an add rating.Vitec Group: Investec cuts target price from 790p to 740p maintaining a buy recommendation.Weir Group: Investec raises target price from 2400p to 2525p, but still recommends selling.William Hill: Numis reduces target price from 500p to 400p downgrading to add.888 Holdings: Numis cuts target price from 220p to 175p and keeps a buy recommendation.32Red: Numis lowers target price from 100p to 80p, while retaining its buy recommendation.
More News
9 Jan 2024 10:50

Novartis in advanced talks to buy Cytokinetics- source

Jan 9 (Reuters) - Swiss drugmaker Novartis is in the lead to acquire Cytokinetics in a deal that could value the drug developer at well over $10 billion, a source familiar with the matter said on Monday.

Read more
8 Jan 2024 14:08

Late M&A bonanza stokes healthcare dealmakers ahead of JPMorgan conference

NEW YORK, Jan 5 (Reuters) - Healthcare dealmakers are making their way to San Francisco for a major industry conference, optimistic that more deals are in the offing after a wave of biotech company takeovers at the end of last year.

Read more
6 Jan 2024 17:44

Late M&A bonanza stokes healthcare dealmakers ahead of JPMorgan conference

NEW YORK, Jan 5 (Reuters) - Healthcare dealmakers are making their way to San Francisco for a major industry conference, optimistic that more deals are in the offing after a wave of biotech company takeovers at the end of last year.

Read more
5 Jan 2024 12:00

Late M&A bonanza stokes healthcare dealmakers ahead of JPMorgan conference

NEW YORK, Jan 5 (Reuters) - Healthcare dealmakers are making their way to San Francisco for a major industry conference, optimistic that more deals are in the offing after a wave of biotech company takeovers at the end of last year.

Read more
3 Jan 2024 17:48

London close: Stocks fall amid rising geopolitical concerns

(Sharecast News) - London stocks closed lower on Wednesday - the 40th anniversary of the FTSE 100's launch - as sentiment remained cautious due to increasing tensions in the Middle East.

Read more
3 Jan 2024 16:52

LONDON MARKET CLOSE: Stocks down ahead of US Fed minutes

(Alliance News) - Stock prices in London closed lower on Wednesday, as investors nervously look ahead to the latest US Federal Reserve meeting minutes.

Read more
3 Jan 2024 11:07

Jefferies upgrades GSK to 'buy', cuts AstraZeneca to 'hold'

(Sharecast News) - Jefferies has upgraded its rating on GlaxoSmithKline to 'buy' and cut AstraZeneca to 'hold' as part of its review of the European pharma sector.

Read more
3 Jan 2024 10:16

IN BRIEF: Nuformix narrows annual loss as develops drug assets

Nuformix PLC - London-based developer of treatments for fibrosis and oncology via drug repurposing - Pretax loss narrows to GBP927,972 in 18 months that ended September 30 from GBP1.3 million in the 12 months that ended March 31, 2022, following its change of financial year-end. Has no meaningful revenue in either period, so reduced loss is due to lower administrative expenses.

Read more
3 Jan 2024 10:12

AIM WINNERS & LOSERS: C4X gets Astra payment; Getech wins eight deals

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Wednesday.

Read more
3 Jan 2024 09:23

LONDON BROKER RATINGS: GSK raised to 'buy'; AstraZeneca cut to 'hold'

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
3 Jan 2024 08:58

LONDON MARKET OPEN: Stocks mixed pre-Fed minutes, amid Asia losses

(Alliance News) - Stock prices in London opened mixed on Wednesday, ahead of US Federal Reserve meeting minutes and manufacturing PMI data for the US in the evening and afternoon respectively.

Read more
3 Jan 2024 08:04

C4X receives USD11 million from AstraZeneca following NRF2 trials

(Alliance News) - C4X Discovery Holdings PLC on Wednesday said it has received payment from AstraZeneca PLC following trials of the C4X respiratory disease therapy treatment.

Read more
3 Jan 2024 07:54

LONDON BRIEFING: Stocks to open flat pre-Fed minutes, jobs data

(Alliance News) - The FTSE 100 is expected to open flat on Wednesday, as London's flagship index celebrates its 40th anniversary, after mostly downbeat trading in Asia and a tech sell-off in New York.

Read more
2 Jan 2024 17:05

British equities slip on higher yields, financials drag

FTSE 100 down 0.2%, FTSE 250 off 0.9%

*

Read more
2 Jan 2024 12:01

LONDON MARKET MIDDAY: London stocks make largely soft start to 2024

(Alliance News) - Stock prices in London were mostly lower at midday on Tuesday in a slow start to the new year, reacting to the UK manufacturing sector finishing a tricky 2023 with a further contraction in December.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.